4//SEC Filing
NOVELION THERAPEUTICS INC. 4
Accession 0001104659-17-031892
CIK 0000827809operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:02 PM ET
Size
9.4 KB
Accession
0001104659-17-031892
Insider Transaction Report
Form 4
Louis Roger
See Remarks
Transactions
- Exercise/Conversion
Common Shares
2017-05-09+547→ 547 total - Tax Payment
Common Shares
2017-05-09$9.42/sh−162$1,526→ 385 total - Exercise/Conversion
Restricted Stock Units
2017-05-09−547→ 1,093 total→ Common Shares (547 underlying)
Footnotes (4)
- [F1]Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016.
- [F2]Each restricted stock unit represents a contingent right to receive one common share.
- [F3]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person.
- [F4]33.34% of the grant vested on May 9, 2017. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 33.33% of the grant will vest on May 9, 2018 and 33.33% of the grant will vest on May 9, 2019.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000827809
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:02 PM ET
- Size
- 9.4 KB